Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
ADELAIDE, Australia--(BUSINESS WIRE)--Australian biotech company Ferronova announced today that it has signed a licensing agreement…